LLY

765.17

-2.47%↓

JNJ

149.65

-0.8%↓

NVO

73.86

-0.31%↓

ABBV

185.03

-0.19%↓

UNH

301.85

-1.71%↓

LLY

765.17

-2.47%↓

JNJ

149.65

-0.8%↓

NVO

73.86

-0.31%↓

ABBV

185.03

-0.19%↓

UNH

301.85

-1.71%↓

LLY

765.17

-2.47%↓

JNJ

149.65

-0.8%↓

NVO

73.86

-0.31%↓

ABBV

185.03

-0.19%↓

UNH

301.85

-1.71%↓

LLY

765.17

-2.47%↓

JNJ

149.65

-0.8%↓

NVO

73.86

-0.31%↓

ABBV

185.03

-0.19%↓

UNH

301.85

-1.71%↓

LLY

765.17

-2.47%↓

JNJ

149.65

-0.8%↓

NVO

73.86

-0.31%↓

ABBV

185.03

-0.19%↓

UNH

301.85

-1.71%↓

Search

10X Genomics Inc (Class A)

Chiusa

SettoreSettore sanitario

10.82 -0.28

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

10.64

Massimo

10.84

Metriche Chiave

By Trading Economics

Entrata

15M

-34M

Vendite

-10M

155M

EPS

-0.102

Margine di Profitto

-22.183

Dipendenti

1,306

EBITDA

-1.5M

-39M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+19.6% upside

Dividendi

By Dow Jones

Utili prossimi

7 ago 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

222M

1.3B

Apertura precedente

11.1

Chiusura precedente

10.82

Notizie sul Sentiment di mercato

By Acuity

34%

66%

105 / 381 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

10X Genomics Inc (Class A) Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

20 giu 2025, 18:52 UTC

Utili

Accenture Shares Fall on Bookings Decline, Concerns over Federal Government Contract -- 3rd Update

20 giu 2025, 16:15 UTC

Acquisizioni, Fusioni, Takeovers

Canadian Natural Selling Control of Gas Plant to Secure Approval for Schlumberger Deal

20 giu 2025, 20:50 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Financial Services Roundup: Market Talk

20 giu 2025, 20:50 UTC

Discorsi di Mercato
Utili

Tech, Media & Telecom Roundup: Market Talk

20 giu 2025, 20:50 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

20 giu 2025, 20:13 UTC

Utili
Acquisizioni, Fusioni, Takeovers

These Stocks Moved the Most Today: Tesla, Accenture, GMS, CarMax, Circle Internet, Smith & Wesson, Kroger, and More -- Barrons.com

20 giu 2025, 20:11 UTC

Discorsi di Mercato

Natural Gas Slides in Late-Week Profit Taking -- Market Talk

20 giu 2025, 19:56 UTC

Discorsi di Mercato

Crude Oil Slips to End Week -- Market Talk

20 giu 2025, 18:35 UTC

Discorsi di Mercato

Warehouse Clubs Seen Growing Market Share -- Market Talk

20 giu 2025, 18:12 UTC

Discorsi di Mercato

Gold Slides to Close Shortened Week -- Market Talk

20 giu 2025, 17:56 UTC

Discorsi di Mercato

Baker Hughes Reports Slight Decrease in U.S. Rig Count -- Market Talk

20 giu 2025, 17:50 UTC

Utili
Acquisizioni, Fusioni, Takeovers

These Stocks Are Moving the Most Today: Tesla, Accenture, GMS, CarMax, Circle Internet, Smith & Wesson, Kroger, and More -- Barrons.com

20 giu 2025, 17:35 UTC

Acquisizioni, Fusioni, Takeovers

Cisco Was the Dot-Com Bust's Biggest Loser. Now It's at a 25-Year High. -- Barrons.com

20 giu 2025, 17:30 UTC

Discorsi di Mercato
Utili

Adobe's AI Headwinds Seen Fading -- Market Talk

20 giu 2025, 17:03 UTC

Utili

Accenture Earnings Beat Expectations. Why the Stock Is Falling Anyway. -- Barrons.com

20 giu 2025, 16:50 UTC

Discorsi di Mercato
Utili

Global Equities Roundup: Market Talk

20 giu 2025, 16:50 UTC

Discorsi di Mercato
Utili

Accenture Seeing Companies Shift to Leapfrog Mentality -- Market Talk

20 giu 2025, 16:44 UTC

Acquisizioni, Fusioni, Takeovers

Meet QXO, the Upstart Building Materials Stock That May Battle Home Depot for GMS -- Barrons.com

20 giu 2025, 16:40 UTC

Discorsi di Mercato
Utili

Accenture Can't Yet Estimate Longer Term Impact from Federal Cuts -- Market Talk

20 giu 2025, 16:20 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Financial Services Roundup: Market Talk

20 giu 2025, 16:20 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

20 giu 2025, 16:17 UTC

Acquisizioni, Fusioni, Takeovers

UniCredit: ULI and UVA Are Expected to Merge in 2026

20 giu 2025, 16:17 UTC

Acquisizioni, Fusioni, Takeovers

UniCredit: Alessandro Santoliquido has been appointed CEO of both companies alongside his role as Head of Group Insurance

20 giu 2025, 16:05 UTC

Discorsi di Mercato

Gold Futures on Track to End Week Lower Despite Haven Demand -- Market Talk

20 giu 2025, 15:56 UTC

Discorsi di Mercato
Utili

Accenture Says Federal Business Had Immaterial Impact to Growth -- Market Talk

20 giu 2025, 15:26 UTC

Discorsi di Mercato

Natural Gas Slips After Streak of Higher Closes -- Market Talk

20 giu 2025, 15:25 UTC

Acquisizioni, Fusioni, Takeovers

Regulator Says Satisfied Sale Would Preserve Competition in Area Around Seiu Processing Plant

20 giu 2025, 15:25 UTC

Acquisizioni, Fusioni, Takeovers

Competition Bureau Says Canadian Natural to Sell 75% Stake in Seiu Lake Natural Gas Plant to North 40 Resources

20 giu 2025, 15:25 UTC

Acquisizioni, Fusioni, Takeovers

Canada Antitrust Regulation Reaches Agreement With Canadian Natural Resources Over Proposed Buy of Schlumberger JV Interest

20 giu 2025, 15:09 UTC

Discorsi di Mercato

Canadian Retail Sales Show Reversal of Tariff Front-Running -- Market Talk

Confronto tra pari

Modifica del prezzo

10X Genomics Inc (Class A) Previsione

Obiettivo di Prezzo

By TipRanks

19.6% in crescita

Previsioni per 12 mesi

Media 13 USD  19.6%

Alto 18 USD

Basso 9 USD

Basato su 10 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per 10X Genomics Inc (Class A) - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

10 ratings

4

Acquista

6

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

8.32 / 8.63Supporto e resistenza

A breve termine

Bullish Evidence

A termine intermedio

Bullish Evidence

A lungo termine

No Evidence

Sentiment

By Acuity

105 / 381 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.